Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLseg Us F 34 S Regulatory News (BW42)

Share Price Information for Lseg Us F 34 S (BW42)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
BW42 Live PriceLast checked at - London Stock Exchange

Intraday Lseg Us F 34 S Share Chart

Stabilisation Notice

30 Apr 2024 14:21

RNS Number : 6559M
Morgan Stanley & Co. LLC
30 April 2024
Β 

30 April 2024

LSEG US Fin Corp.

Post-stabilisation Period Announcement

Further to the pre-stabilisation period announcement dated 25 March, Morgan Stanley & Co. LLC (contact: Morgan Stanley Debt Syndicate - Kristen Powers; telephone: +1 212 761-7030) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the EU Market Abuse Regulation (596/2014), including as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018) was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.

Securities

Issuer:

LSEG US Fin Corp.

Guarantor(s) (if any):

London Stock Exchange Group plc

Aggregate nominal amount:

2027 Notes: $500,000,000

2034 Notes: $750,000,000

Description:

US$ Fixed Rate Notes due 2027 (the "2027 Notes")

US$ Fixed Rate Notes due 2034 (the "2034 Notes")

ISIN:

2027 Notes: US50222CAA80

2034 Notes: USU54639AB22

Offer price:

2027 Notes: 99.518%

2034 Notes: 100.000%

Β 

Stabilisation

Stabilisation Manager(s):

BofA Securities, Inc.

Citigroup Global Markets Inc.

HSBC Securities (USA) Inc.

Morgan Stanley & Co. LLC

Wells Fargo Securities, LLC

Β 

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
STAIMMJTMTTJBBI
Date   Source Headline
20th Mar 202611:00 amRNSPublication of Offering Circular
19th Mar 20261:00 pmRNSPublication of Offering Memorandum
12th Mar 202610:30 amRNSAnnual Report and Accounts
15th Dec 20251:30 pmRNSPublication of supplement to Offering Circular
30th Oct 202512:45 pmRNSPublication of supplement to Offering Circular
18th Sep 20259:40 amRNSPublication of Final Terms
8th Aug 20251:50 pmRNSPublication of supplement to Offering Circular
28th Mar 20254:05 pmRNSPublication of Offering Circular
26th Mar 20255:27 pmRNSAnnual Financial Report
25th Sep 202412:30 pmRNSPublication of Final Terms
18th Sep 20244:15 pmRNSPublication of Final Terms
1st Aug 20241:05 pmRNSPublication of Supplement to Offering Circular
30th Apr 20242:21 pmRNSStabilisation Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.